Article

Angiopoietin-1 requires IQ domain GTPase-activating protein 1 to activate Rac1 and promote endothelial barrier defense.

Center for Vascular Biology Research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Arteriosclerosis Thrombosis and Vascular Biology (impact factor: 6.37). 09/2011; 31(11):2643-52. DOI:10.1161/ATVBAHA.111.233189 pp.2643-52
Source: PubMed

ABSTRACT IQ domain GTPase-activating protein 1 (IQGAP1) contributes to cytoskeletal network regulation in epithelial cells by its scaffolding properties and by binding the Rho GTPase Rac1 to maintain its activity. The functions of IQGAP1 in endothelial cells beyond angiogenesis remain unclear. We hypothesized that IQGAP1 participates in the regulation of endothelial barrier function.
Silencing IQGAP1 in human microvascular endothelial cells resulted in a disruption of adherens junctions, formation of interendothelial gaps, and a reduction in barrier function. Furthermore, silencing of IQGAP1 abrogated the barrier enhancement effect of angiopoietin-1 (Angpt-1) and abolished the barrier-stabilizing effect of Angpt-1 on thrombin-stimulated cells. Coimmunoprecipitation detected binding of endogenous IQGAP1 with Rac1 at baseline that was stronger when Rac1 was activated and weaker when it was deactivated. Measurement of GTP-bound Rac1 revealed that Angpt-1 failed to activate Rac1 not only if IQGAP1 was silenced but also if cells were transfected with a mutant disabled in Rac1 binding (T1050AX2). Furthermore, a dominant-active Rac1 was sufficient to completely reverse the morphological and functional changes induced by reduction in IQGAP1.
These experiments are the first demonstration of IQGAP1 regulating barrier function in any cell type. Further, our data show that Angpt-1 requires IQGAP1 as an indispensable activator of Rac1.

0 0
 · 
0 Bookmarks
 · 
74 Views
  • Source
    Article: IQGAP1 is necessary for pulmonary vascular barrier protection in murine acute lung injury and pneumonia.
    [show abstract] [hide abstract]
    ABSTRACT: We recently reported that integrin α(v)β(3) is necessary for vascular barrier protection in mouse models of acute lung injury and peritonitis. Here, we used mass spectrometric sequencing of integrin complexes to isolate the novel β(3)-integrin binding partner IQGAP1. Like integrin β(3), IQGAP1 localized to the endothelial cell-cell junction after sphingosine-1-phosphate (S1P) treatment, and IQGAP1 knockdown prevented cortical actin formation and barrier enhancement in response to S1P. Furthermore, knockdown of IQGAP1 prevented localization of integrin α(v)β(3) to the cell-cell junction. Similar to β(3)-null animals, IQGAP1-null mice had increased pulmonary vascular leak compared with wild-type controls 3 days after intratracheal LPS. In an Escherichia coli pneumonia model, IQGAP1 knockout mice had increased lung weights, lung water, and lung extravascular plasma equivalents of (125)I-labeled albumin compared with wild-type controls. Taken together, these experiments indicate that IQGAP1 is necessary for S1P-mediated vascular barrier protection during acute lung injury and is required for junctional localization of the barrier-protective integrin α(v)β(3).
    AJP Lung Cellular and Molecular Physiology 05/2012; 303(1):L12-9. · 3.66 Impact Factor

Keywords

activate Rac1
 
adherens junctions
 
barrier enhancement effect
 
cytoskeletal network regulation
 
dominant-active Rac1
 
endogenous IQGAP1
 
endothelial barrier function
 
endothelial cells
 
epithelial cells
 
first demonstration
 
GTP-bound Rac1
 
human microvascular endothelial cells
 
indispensable activator
 
interendothelial gaps
 
IQGAP1 participates
 
IQGAP1 regulating barrier function
 
Rac1 binding
 
Rho GTPase Rac1
 
Silencing IQGAP1
 
thrombin-stimulated cells